The END Fund

The END Fund is a philanthropic nonprofit focussed on ending neglected tropical diseases (NTDs). The US-based fund, established by Legatum Foundation in 2012, utilises private capital to invest in sustainable programmes tackling NTDs .

  • Organisation type Corporate giving
  • Year founded 2012
  • Headquartered New York
  • Registration United States
  • Website

Related sustainable development goals

  • Good Health and Well-Being
  • Clean Water and Sanitation
  • Reduced Inequalities


1.5b+ people treated

US$ 2.3b+ value of treatments

5m+ health workers trained

Focus areas

Focus sectors

  • Health
    • Diseases and conditions
      • Infectious and parasitic diseases
  • Philanthropy
    • Foundations
    • Venture philanthropy
    • Nonprofits

Focus populations

  • Low-income people

Focus geographies

  • Africa
    • Niger
    • Cote d'Ivoire
    • South Sudan
    • Namibia
    • Liberia
    • Tanzania
    • Somalia
    • Rwanda
    • Mauritania
    • Zambia
    • Eritrea
    • Angola
    • Chad
    • Kenya
    • Madagascar
    • DR Congo
    • Senegal
    • Burundi
    • Nigeria
    • Central African Republic
    • Zimbabwe
    • Ethiopia
    • Sudan
    • Mali
    • Congo R
  • Middle East
    • Yemen
  • South Asia
    • Afghanistan
    • India


  • World Food Programme (WFP)
  • World Health Organisation


  • Reaching the Last Mile
  • WHO


  • Deworming Innovation Fund

    This programme works on eliminating health burdens caused by paracitic worm infections - intestinal worms and schistosomiasis.

  • Flagship Fund

    Provides access to treatment for five top NTDs.

  • Reaching the Last Mile Fund

    Aims to eliminate river blindness and lymphatic filariasis (LF).



  • US$ 45,000,000 annual spend

Funding model

  • Programme related investment

Primary funders

  • Al Ansari Exchange
  • Astellas Global Health Foundation
  • Bill & Melinda Gates Foundation
  • Cambell Family Foundation
  • Children's Investment Fund Foundation
  • Delta Philanthropies
  • Dubai Cares
  • Good Ventures
  • Jackson Kemper Foundation
  • Jeffrey and Marieke Rothschild
  • Latter Day Saints
  • Legatum Group
  • Mackenzie Scott
  • Margaret A. Cargill Philanthropies
  • MSD Foundation
  • Shefa Fund
  • Sint Antonius Stichting Projecten
  • The Elma Foundation
  • The Leona M. and Harry B. Helmsley Charitable Trust
  • The Moondance Foundation
  • UAE Presidential Court
  • UBS Optimus Foundation
  • UK AID
  • Virgin Unite
  • Wyss Medical Foundation

Funding source

  • Pooled fund


Key staff

  • Ellen Agler, CEO

Board members

  • Tsitsi Masiyiwa, chair
  • Kesetebirhan (Kesete) Admasu
  • Robyn Calder
  • Michael P. Hoffman
  • Faustina Fynn-Nyame
  • Alan McCormick
  • Christine Wächter-Campbell
  • Moses Bockarie
  • Temitope Lawani
  • Scott Powell
  • English Sall
  • William I. Campbell
  • Katey Owen

Contact details



Op-ed: CEO of the END Fund, Ellen Agler, talks about patient philanthropy and the importance of understanding systems before trying to change them. Read more

Podcast: In this podcast episode of Philanthropy Age's The Impact Room, Agler talks to host Maysa Jalbout about the challenges of last-mile disease elimination. Listen to the episode here

Reframing Neglect: The END Fund commissioned a photography show by seven African artists who showcase images depicting the harsh reality and disproportional impact of neglected tropic diseases (NTDs). Read more

More from the End Fund: